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In the paediatric wards of African hospitals in 
Rhodesia cross-infection with measles is still a 
serious problem, associated with high morbidity 
and mortality. The ideal solution to this problem 
would foe wide-spread immunisation of the child 
population against measles, but this goal seems un­
attainable in the near future because of considera­
tions of economics and manpower. An alternative 
solution is the immunisation of patients on admis­
sion to hospital, but though the safety and effec­
tiveness of live virus vaccine is widely accepted, its 
use in acutely ill children is still debatable. Argu­
ments against its use are that reaction to the vac­
cine may be detrimental to an already ill child, 
that in the presence of acute illness and malnutri­
tion a good antibody response may not be ob­
tained, and that vaccination may not foe carried 
out early enough to prevent infection. The present 
study was carried out to test the validity of these 
arguments, and included an assessment of the pro­
tection afforded by pooled human immune globu­
lin, which is often recommended for children in 
whom it is felt to be unsafe to use live virus vac­
cination.
Material and methods
When the study was started in May, 1968, 
measles vaccine was not normally available to 
Mpilo Hospital. However, 100 doses of vaccine 
(live attenuated Schwartz strain, “Mevilin-L”, 
Glaxo), which was about to reach its expiry date, 
became available, and it was decided to use this in 
a single-blind controlled trial. As only a limited 
number of patients could be vaccinated there was ' 
no ethical objection to withholding vaccine from 
the control group.
All patients admitted to the paediatric unit 
were included in the study if they were between 
the ages of six months and,35 months (inclusive), 
had not had measles, were not thought to have 
measles on admission, and were alive on the morn­
ing following the day of admission. The last con­
dition was a practical necessity, but did result 
in the exclusion of a number of very ill patients. 
The vast majority of patients were admitted for 
malnutrition, acute infection, or both, and none 
were excluded because of the nature or severity 
of their illness. Patients were assigned consecu­
tively to one of three treatment groups:
1. Hum an immune globulin (Gamma Globulin, South 
African Institute for Medical Research), 2 ml. by 
intramuscular injection on the day after admission, 
repeated a t 3-weekly intervals until discharge.
2. No treatment.
3. Measles vaccine, 1 dose by intramuscular injection 
on the day after admission.
All assessment of the patients was carried out 
by the author, who was not aware of the treatment 
code, which had been assigned by a colleague and 
given to the senior ward sisters, who carried out 
all treatments. Arrangements were made so that 
the code would -not be inadvertently broken by re­
quests for ordering of vaccine or written records 
on the treatment charts. Patients were observed 
for signs which might indicate vaccine reactions or 
natural measles, viz. pyrexia, rash, Koplik’s spots 
and conjunctivitis. On discharge all patients who 
had not contracted measles were requested to at­
tend for follow-up one. week and two weeks after 
discharge in addition to any normal attendances
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which were indicated. More frequent attendances 
were required in patients who were discharged 
while still being observed for vaccine reactions. 
Any patient who was not completely well at the 
two week follow-up was seen again until there 
was no further suspicion of their developing 
measles. No long term follow-up was considered 
practicable. -
As the early months of the study coincided with 
an exceptionally severe epidemic of measles, an 
unusually high proportion of admissions had or 
had recently suffered from measles, so that cases 
were accumulated rather slowly. The study was 
discontinued for a period of 31 days when the 
author was on leave and was concluded in June 
1969, thus covering a period of just over 13 
months. Two doses of vaccine were wasted by 
being given to non-susceptible cases, leaving 98 
cases in group 3. Group 2, the control group, also 
consisted of 98 cases, but Group 1 contained only 
95 cases as stocks of globulin were exhausted 
shortly before the conclusion of the study. The 
status of cases included in and excluded from the 
series is summarised in Taible I.
The age distribution and the main diagnoses in­
cluded in the three groups are summarised in 
Tables II and III respectively, from which it can 
be seen that no major bias is likely to have been 
introduced by these variables.
Table I
Total cases admitted under the age of 3 years ...  2090
Excluded: Died on first day of admission ............ 197
Less than 6 months of age ....................  392
Diagnosed as measles on admission . ...  163
Discharged or transferred to other wards
on day of admission ...............................  114
History of previous measles ......................  933
1799
Included in study: Group 1 ................................... 95
Group 2 ................................... 98
Group 3 ................................... 98
291
Table II
Age D istribution of the  T hree Study Groups
Number of cases
Age in months Group 1 Group 2 Group 3
6-11 ' 40 39 46
12-17 ■ 29 40 33
18-23 12 11 13
24-35 14 8 6
Results
The data obtained were analysed to determine 
the incidence and severity of vaccine reactions, the 
contribution of vaccine reactions to death and 
deterioration of patients, and the degree of pro­
tection against measles contracted in the ward af­
forded by vaccine and globulin. No attempt was 
made to assess long term protection from measles 
and no serum antibody studies were possible. 
Vaccine reactions (See Table IV)
It was arbitrarily assumed that reactions were 
most likely to occur eight to 16 days after admis­
sion to hospital, and though this is not necessarily 
accurate, minor variations in the period chosen 
would not materially change the results. Cases 
who had developed measles or died before the 
eighth day were excluded, and those who were dis­
charged before the sixteenth day were only in­
cluded if they attended for follow-up at least on 
alternate days during the period of an expected 
reaction. Patients who developed measles during 
the “reaction period” presented a problem, as they 
could have had either natural measles or severe 
vaccine reactions. However: in the event, this was 
not important as only one such case had received 
vaccine. 'j
Table IV shows the numbers of patients in the 
three groups who develope'd pyrexia, showed a 
probable vaccine reaction or suffered exacerbation 
of their illness over the reaction period. Differ­
ences between the groups were small, and by the 
chi square test failed to show even suggestive 
levels of statistical significance. The value of the 
“blind” technique was Shown by the diagnosis of 
vaccine reaction in five cases who had not received 
vaccine! The four “reactions” observed in .the
Table III
Main D iagnosis of Patients in  the T hree 
Study G roups
Diagnosis Group 1 Group 2 Group 3
Gastroenteritis .................... 36 38 43
Bronchopneumonia ............ 30 30 27
M alnutrition .... 11 13 12
Meningitis (including TB), >
Encephalitis .................... 6 1 2
Other respiratory tract
infections .... ............ 5 8 4
Malaria ............ ............ 2 0 2
Anaemia .................................... 1 2 1
Congenital heart disease 0 2 1
Acute leukemia .................... 0 1 1
O ther: Osteomyelitis, Polio-
myelitis, Septicaemia, Men-
tal retardation, Unknown ... 5 3 5
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globulin group may well' have been natural , 
measles modified by the globulin.
It has been suggested by Lightwood (1967) in 
Harare Hospital that vaccine reactions have oc­
casionally contributed to the death of a very sick 
child. However, the figures quoted in Table IV do 
not support this suggestion either for death in the 
reaction period or later. Even without comparison 
with the control group, it is unlikely that the vac­
cine would have been implicated in the deaths in 
our vaccinated group, as the one occurring in the 
reaction period- was associated with septicaemia, 
pyaemic abscesses and inferior vena caval throm­
bosis — surely sufficient to explain death, and the 
later deaths were due to relapse of bronchopneu­
monia which had appeared to improve for some 
time after the sixteenth day.
Protection against measles. (See Table V.) .
It was assumed that measles diagnosed on the 
tenth day after admission or later had been con­
tracted in the ward. This assumption was again 
arbitrary, but seems to be borne out by our results. 
Measles diagnosed after the sixteenth day was al­
most certainly contracted in the ward, and so has 
been tabulated separately. Cases developing 
measles before the tenth day were probably in­
cubating the disease when they were admitted and 
so have been excluded. Cases who were not known 
to have measles but died or were lost to follow-up 
might have developed measles and so could not 
be used to assess the protection of vaccine or 
globulin and were excluded.
It is apparent from Table V that very few cases 
developed measles after vaccination compared 
with a very large number in the control group and 
an intermediate number in the globulin group. 
The overall risk of contracting measles in the three 
groups was:— vaccine: 2.0-2.9 per cent.; globulin: 
13.7-19.1 per cent.; control: 34.0-46.6 per cent. A 
more accurate comparison between the groups can 
be based on the data of Table VI. Measles develop­
ing on the tenth to sixteenth day in hospital might 
have been confused with vaccine reactions, though 
this turned out to be possible in only one cas'e, and 
might represent disease already incubating on ad­
mission. Even with these reservations the protec­
tive effect Of both vaccine and globulin is shown 
to be significant, while there were too few cases 
to compare vaccine with globulin. Cases develop­
ing measles after the sixteenth day diagnosed in 
the ward and after discharge were combined for 
the purpose of analysis. Again the protective effect 
of both vaccine and globulin was highly significant, 
but In .these the difference between vaccine and 
globulin was also highly significant. On combining 
the figures for all cases of measles on the 10th day
or later, the superior protection of vaccine com­
pared with globulin was again demonstrated.
Of the 80 cases at risk in the control group who 
were known not to have died, 11 (13.7 per cent.) 
were re-admitted because of measles or its seque­
lae, against four (4.8 per cent.) of the globulin 
group and two (2.2 per cent.) of the vaccine group. 
Thus protection by vaccine or globulin reduces the 
load on a busy paediatric ward by reducing the 
number of admissions. Twelve deaths occurred in 
the 34 cases of measles in the control group, giving 
a mortality of 35.3 per cent. This high mortality 
presumably results from the superimposition of 
measles on the other illnesses from which these 
children were suffering. There were insufficient 
cases to draw definite conclusions on the mortality 
of measles in the vaccine and globulin groups, but 
in these groups as a whole a  significant reduction I 
in the death rate was effected by vaccine or globu­
lin. There were too few cases to compare the vac­
cine and globulin groups in this respect.
Modified measles
A mild illness with rash, pyrexia and Koplik’s . 
spots was observed in seven cases, and was pre­
sumed to represent modified measles, though 
before the treatment code was broken five of these 
were considered to be vaccine reactions. One was 
a nine-month-old child in the control group in 
whom an attack of natural measles might have 
been modified by late persistence of maternal anti­
bodies. Four had received globulin, and were pre­
sumably natural measles modified by the globulin. 
In the vaccine group one case developed on the 
twelfth day, and it is impossible to be sure whether 
this was a. vaccine reaction or natural measles 
modified by vaccine given early in the incubation 
period; one developed on the thirty-sixth day in 
an 11-month-old malnourished child and was pre­
sumably natural measles modified by incomplete 
immunity produced by vaccination. Without virus 
culture and antibody determinations one cannot, 
of course, exclude the possibility that any of these 
illnesses were due to other viruses mimicking 
measles.
Length of stay in hospital
If there had been significant differences between 
the three groups in duration of hospitalisation, the 
risk of contracting measles might have differed 
between them. However Table VII (a) shows that 
there were actually more early discharges in the 
control group, thus strengthening rather than in­
validating our results. The incidence of measles 
had little overall effect on the figures for length of 
stay in hospital, as the delay in discharge due to 
cases contracting measles was offset by the increase 
in deaths and transfers to the isolation hospital in 
these cases.
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Duration of exposure and risk of contracting 
measles. (Table VII (b ) .)
Though not strictly relevant to the study, it is 
of interest to see when in their stay in hospital 
patients contracted measles. Because of uncertainty 
about the duration of the incubation period, ac­
curate figures cannot be quoted, but it appears 
that the majority of cases were infected in their 
first week in hospital. However, despite the num­
ber at risk being rapidly reduced by discharges, 
cases were still being infected in their fourth week 
' in hospital. Only after about five to six weeks’ ex­
posure to The ward does one seem to reach the 
stage where most of the susceptible patients have 
acquired the infection. This has the practical im­
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plication that to attempt to avoid infection by 
early discharge of cases is practically useless, and 
yet it cannot be assumed that because a child has 
been in the ward for several weeks without de­
veloping measles he is immune.
It is interesting that when patients are closely 
observed a prodromal illness lasting eight to 15 
days can often be distinguished. In some cases 
this took the form of an initial pyrexia with upper 
respiratory infection, followed by a period of ap­
parent normality until the onset of clinical 
measles; in others there was gradually increasing 
illness and pyrexia through the whole incubation 
period, the nature of which was obscure until 
finally measles developed.
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Table IV
Data Relevant to the Occurrence of Possible Vaccine Reactions in  the T hree Study Groups
: Group 1 Group 2 Group 3
Cases excluded:—
Measles developed on l-7th hospital day .......................................................................... ; 1 1 0
Died on l-7th hospital day (excluding death associated with measles) ..................... i. 3 2 3
Discharged before 16th hospital day and inadequate follow-up ...........................................!' 16 15 19
Measles developed on 8-16th hospital day ........................................................................... 2 12 1
Total cases excluded .................................................................................................................... i 22 30 23
Cases remaining .............. ........................  ...................................................... l! 73 68 75
Pyrexia on 8-16th hospital day (excluding cases of measles) 100° - 102°F.......................... 12 13 16
more than 102°F.....................................................................  ............................................ 11 7 10
Probable vaccine reaction, i.e. rash and pyrexia (excluding measles cases) ....................... 4 1 3
Exacerbation of illness on 8-16th hospital day (excluding cases of measles and deaths) 14 9 13
Deaths on 8-16th hospital day (not associated with measles) ............................................ 2 2 1
Deaths later than 16th hospital day (not associated with measles) .................................. 2 1 2
Table V
Measles in  the T hree Study Groups
Group 1 Group 2 Group 3
Cases excluded:—
Measles developed on l-9th hospital day .. ............................................. 1 1 0
Died on l-9th hospital day (not associated with measles) ............................................. 3 3 0
Died on 10th day or later (not associated with measles) ............................................. 4 2 6
Did not develop measles in ward but lost to follow-up .............. .............. 19 19 22
- Total cases excluded .............. 27 25 28
Cases remaining 68 73 70
Measles (in ward or on follow-up) on 10-16th day 2 12 1
Measles in ward later than 16th day 4 8 0
Measles on follow-up, later than 16th day, within two weeks of discharge 7 14 1
Re-admissions associated with measles or sequelae of measles contracted in ward 4 11 ' 2
Death associated with measles developing on 10th day or later 3 12 1
Modified measles on 10-16th day 3 1 1
Modified measles after 16th day i 0 1
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Table VI
Statistical Significance of D ifferences Between N umbers of Cases Contracting Measles in  
the T hree Groups. Results of Ch i Square Tests on Data of Table V, Values of p . (N.S. =  not
Significant) .
Values of p in comparison of groups
1 and 2 2 and 3 1 and 3
Measles on 10-16th day ................................................................................................
All measles later than 16th day ...  .......................................................
All measles on 10th day or later ............................................................................
Deaths associated with measles developing on 10th day o r la te r ........................
<  .01 
= .0 5
<  .005
<  .025
- <  .005
<  .005
<  .005
<  .005
N.S.
<  .005
<  .005 
N.S.
Table VIII
(a) Length of Stay of Cases in  H ospital, (to) I nterval Between Day of A dmission and Day on 
Which  D iagnosis Was Made in  Cases W ho Developed Measles.
Hospital days (a )  Number of cases discharged or died (b ) Number of cases who developed measles
Group 1 Group 2 Group 3 .Group 1 G roup/2 Group 3
0 -  4 ........................ 9 10 6 1 0 0
5 -  8 ' .............. .... 29 31 27 0 1 0
9 -1 2  ........................ 21 13 22 0 2 0
13-16  ........................ 11 9 10 2 10 1
17 - 20 ........................ 1 7 8 4 9 0
21 - 24 ........................ 8 7 4 5 3 1
25 - 28 ........................ 6 7 6 2 3 0
29 -3 2  ........................ 5 4 4 0 3 0
33 - 36 ........................ 1 2 0 0 3 0
37 - 40 ........................ 1 1 1 0 1 0
more than 40 .............. 3 7 10 0 0 0
D iscussion
There is ample documentation (Krugman and 
Ward, 1964) of the effectiveness and safety of 
measles vaccine in field trials and institutionalised 
patients, including those suffering from tubercul­
osis, tout there are hardly any reports of its routine 
use in acutely, ill children. In fact, acute illness of 
any kind or any degree of severity is 'listed as a con­
tra-indication to vaccination in the literature sup­
plied with the Glaxo vaccine and all others known 
to the author. A trial similar to ours was reported 
by Wagstaff from Baragwanath Hospital, Johannes­
burg, dealing with a series of 312 cases of whom 
214 were vaccinated. This study which was initiated 
atabout the same timeias ours, differs in that there 
was no control group in the same ward, thus re­
ducing the exposure to infection of the cases 
studied, some cases were excluded on the grounds 
of severe illness, antibody levels were determined, 
though these seem to have introduced complica­
tion as much as illumination, and human immune 
globulin prophylaxis was not studied. Wagsitaff’s 
findings will be discussed further with our own 
results.
The questions we set out to answer were 
whether in our patients vaccine might be detri­
mental because of co-existing illness, and how 
effective a protection against ward cross-infection 
with measles would be achieved, Whether by vac­
cine or globulin. Far from showing detrimental 
effects on the patients, it is impossible to demon­
strate with certainty from our results that vaccine 
reactions which could be clinically diagnosed oc­
curred at all. What is certain is that until there is 
wide-spread vaccination of the child population 
measles contracted in the ward is an infinitely 
greater hazard than vaccination. Dr. Wagstaff 
reaches the same conclusion, and her figures also 
show that even with a large number of the ward 
cases being vaccinated there is still a significant 
risk of measles occurring in the few patients one 
might be tempted not to vaccinate because of 
severe illness.
The protection achieved by vaccination was im­
pressive, even in these ill, often malnourished 
children. The incidence of measles in the vaccine 
group was under three per cent., against over 34 
per cent, in the control group. In Baragwanath the 
incidence of failed vaccination was between 1.5 
and 2.5 per cent. Failure of vaccination will some­
times occur in children in the six to, nine month 
age group because of persistence of maternal anti-.
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bodies; one of our failed case's was eight months 
old, and in Baragwanath oases of six and seven 
months were observed. However, having seen 
several cases of florid measles at five months, with 
one death, we now vaccinate from five months of 
age. Antibody determination would be helpful in 
these cases, and a later repeat vaccination would 
be advisable in some of them. 'It must also be 
borne in mind that passive immunity mediated by 
blood or plasma transfusions will have a similar 
effect in preventing effective vaccination. Malnutri­
tion and/or acute illness may well affect the im­
mune response to measles and vaccine virus, and 
this is supported by findings in Baragwanath that 
patients with antibody titres of 20 or even 40 de­
veloped measles, when by normal criteria they 
should be immune. On the other hand there is evi­
dence that malnourished patients respond normally 
to attenuated measles virus, even when 'given with 
gamma globulin (Scrimshaw, et al., 1968). Even 
with antibody studies Dr. Wagstaff was unable !to 
comment on the likelihood of good long term 
protection being given by vaccination in these cir- 
circumstances, and we have no data as yet on this 
problem.
The protection afforded by globulin was also 
evident in comparison with the control group, but 
was significantly less than that of vaccine. In view 
of the short-lived nature of the protection, and the 
apparent safety of vaccine, there seems to be little 
reason to use globulin except in cases of immuno­
logical defect and malignancy. There might be an 
argument for using globulin in an exceptionally 
ill patient, as our conclusions are based on too 
few cases to affirm .that vaccine reactions will 
never have serious ill-effects on such a patient. 
However, it seems likely that even in such a case 
the risk of developing measles after receiving 
globulin is still significant and is greater than the 
risk of a severe vaccine reaction.
It is difficult to be sure of the reason for failure 
of globulin to prevent or even to produce signifi­
cant modification of measles in so many of our 
cases. The dose given was well above the 0.02 ml. 
per pound body weight generally recommended 
(Krugman and Ward, 1964), but, of course, the 
titre of measles antibody in any particular batch 
of globulin is unknown. The time of peak incid­
ence of measles in the control group suggested 
that the majortity of cases were infected during 
their first week in hospital, whereas the globulin 
group were infected somewhat later, the majority 
towards the end of the second week. Thus though 
the globulin is said to be effective for at least four 
weeks (Krugman and Ward, 1964), It is possible 
that in the presence of 'the catabolic state of acute 
infection and the disordered protein metabolism
of malnutrition, antibody levels dropped more 
rapidly than would be expeoted, permitting infec­
tion to occur before the second dose was given on 
the twenty-first day. There is some evidence that, 
the effect of passive Immunity mediated by exo­
genous gamma globulin administration is modified 
by protein malnutrition (Scrimshaw et al., 1968). 
The complete lack of cases occurring in the globu­
lin group after the twenty-eighth day suggests that 
many of the remaining cases were immune due to 
subclinical or modified infection before that time. 
These conclusions are speculative, and would re­
quire a larger study, preferably with determination 
of antibody levels for confirmation. We feel that 
in our circumstances it would 'be unethical to en­
large on the present study with any trial involving 
a control or globulin group, as our results already 
show beyond reasonable doubt that it is our duty 
to protect our patients with vaccine, which has 
now become available for routine use.
. /^ S ummary
In an acute paediatric ward in which measles 
infection was endemic three groups of children 
aged six to 35 months were given measles vaccine, 
gamma globulin'! or no prophylactic treatment 
against measles. Data are presented on the incid­
ence of measles i,and vaccine reaction in these 
patients. The follojwing conclusions were reached;
1. Measles vaccine given on the day after ad­
mission almost completely prevented cross-
' infection with measles.
2. Gamma globulin approximately halved the 
incidence of cross-infection with measles and 
reduced its severity in many infected cases.
3. Reactions to measles vaccine did not consti­
tute a significant risk even to severely ill and 
malnourished patients.
The overall conclusion was that in the circum­
stances of this study, vaccination against measles 
of susceptible children, even if they are acutely 
ill and malnourished, is not only justified but is 
mandatory.
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